Copper and Human Health- A Review

Authors

  • Nasim Karim

DOI:

https://doi.org/10.51985/JBUMDC2018046

Abstract

Copper (Cu), is an essential trace element. Along with lead, arsenic, mercury, cadmium etc. it is classified as a member of heavy metal group. Deficiency of copper is involved in the etiology and promotion of many disease processes related to gastrointestinal and neurological   systems as well as affect functions of heart, blood vessel, pancreas etc. Deficiency of copper in early part of gestation can produce major organ malformations in the developing fetus and this in turn if persistently present can lead to neurological as well as immunological abnormalities in the newborn. Conversely presence of enormous concentrations of copper is also a great danger for the human health. Acute copper toxicity predisposes to various pathological conditions and can cause death in severe cases. Chronic exposure to copper produces anemia, liver toxicity and severe neurological defects.

References

Wilson L. Toxic metals & detoxification. The center for Development. 2014. Availableat:drlwilson.com/articles/ TOXIC%20METALS.htm. Accessed on 22-5-2018.

Stern B R, Solioz M, Krewski D, Aggett P, Ching Aw T, Baker S et al. Copper and human health: biochemistry, genetics, and strategies for modeling dose-response relationships. Journal of Toxicology and Environmental Health, Part B, 10:157-222, 2007. DOI: 10.1080/10937400600755911

Lenntech . Chemical properties of copper - Health effects of copper - Environmental effects of copper. 2014. Accessed on 23-5-2018 https://www.lenntech.com/periodic/elements

/cu.htm#ixzz5GgRtvtWN

Berglund M, Elinder CG, Jarup L. Humans exposure Assessment. An Introduction. 2001. WHO/SDE/OEH/01.3, 2001:1-210

Barakat MA. Review Article, New trends in removing heavy metals from industrial wastewater. Arabian Journal of Chemistry. 2011; 4(4): 361-77.

Mudgal V, Madaan N, Singh ARB, Mishra S. Effect of Toxic Metals on Human Health. The open Nutraceuticals journal. 2010; 3: 94-9.

Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for Copper. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service. 2008. CAS#: 7440-50-8. Accessed on 23-5-2018.

Turnlund J R. Human whole-body copper metabolism. Am J Clin Nutr. 1998; 67: 960S-4S.

Wapnir R A. Copper absorption and bioavailability. Am J Clin Nutr. 1998; 67: 1054S-60S.

Ralph A, McArdle H J. Copper metabolism and requirements in the pregnant mother, her fetus and children. New York: 2001.International Copper Association.

Harris ED. Cellular copper transport and metabolism. Annu Rev Nutr. 2000; 20: 291-310.

Harris ED. Copper homeostasis: The role of cellular transporters. Nutr Rev 2001; 59: 281-5.

Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr 2002; 22: 439-58.

Turnlund JR, Scott KC, Peiffer GL, Jang AM, Keyes WR, Keen CL et al. Copper status of young men consuming a low- copper diet. Am J Clin Nutr 1997; 65: 72-8

Nasim Karim

Osredkar J, Sustar N. Copper and Zinc, Biological Role and Significance of Copper/Zinc Imbalance. Journal of Clinical Toxicology.2011; S3: 001.

Bamuwamye M, Ogwok P, Tumuhairwe V. Cancer and Non-cancer Risks Associated with Heavy Metal Exposures from Street Foods: Evaluation of Roasted Meats in an Urban Setting. Journal of Environment Pollution and Human Health. 2015; 3 (2)24-30. DOI: 10.12691/jephh-3-2-1

Singh R, Gautam N, Mishra A, Gupta R. Heavy metals and living systems: An overview. Indian J Pharmacol. 2011;43(3): 246-53. doi: 10.4103/0253-7613.81505

Mercer JF. The molecular basis of copper-transport diseases. Trends Mol Med. 2001; 7:64-9.

Hamza I, Gitlin JD Copper chaperones for cytochrome c oxidase and human disease. J Bioenerg Biomembr .2002; 34: 381-8.

Gitlin JD. Wilson disease. Gastroenterology. 2003; 125: 1868- 77.

Kagan H M, Li W. Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell. Journal of Cellular Biochemistry. 2003; 88(4): 660-72. DOI: 10.1002/jcb.10413

Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem. 2005; 12: 1161-1208.

ValkoM, Rhodes CJ, Moncol J. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006; 160: 1-40.

Letelier ME ,Faúndez M,Sandoval JJ , Molina-Berríos A , Cortés-Troncoso J , Aracena-Parks. Mechanisms underlying the inhibition of the cytochrome P450 system by copper ions. Journal of Applied Toxicology. 2009. https://doi.org/ 10.1002/jat.1460. Accessed on 24-5-2018

Ozcelik D, Ozaras R, Gurel Z, Uzun H, Aydin S. Cu-Mediated Oxidative Stress in Rat liver. Biological Trace elements Research. 2003; 96(1-3): 209-15.

IOM: Institute of Medicine, Food and Nutrition Boards. Dietary Reference Intakes. Washington, DC: National Academic Press. 2001; pp.1-769.

Handy RD. Chronic effects of copper exposure versus endocrine toxicity: Two sides of the same toxicological process? Comp Biochem Physiol Part A. 2003; 135: 25-38.

Kodama H, Murata Y. Molecular genetics and pathophysiology of Menkes disease. Pediatr. Int. 1999; 41: 430-5.

Kaler SG. Menkes disease mutations and response to early copper histidine treatment. Nat Genet. 1996; 13: 21-2.

Kaler SG. Metabolic and molecular bases of Menkes disease and occipital horn syndrome. Pediatr Dev Pathol. 1998; 1: 85-98.

Llanos RM, Mercer JF. The molecular basis of copper homeostasis and copper-related disorders. DNA Cell Biol. 2002; 21: 259-70.

Gitlin JD. Aceruloplasminemia. Pediatr. Res. 1998; 44: 271- 6.

IPCS - International Programme On Chemical Safety. IOMC Inter-Organization Programme For The Sound Management Of Chemicals. A cooperative agreement among UNEP, ILO, FAO, WHO, UNIDO, UNITAR and OECD. WHO. Copper No. 200, 1998.

Ferenci P, Caca K, Loudiano G, Mieli-Vergani G, Tanner S,

Sternlieb I et al. Diagnosis and phenotypic classification of Wilson disease. Liver.2003; 23: 139-42.

Wijmenga C, Muller T, Murli IS, Brunt T, Feichtinger H, Schonitzer D et al. Endemic Tyrolean infantile cirrhosis is not an allelic variant of Wilson’s disease. Eur J Hum Genet. 1998; 6: 624-8.

Muller T, MullerW, Feichtinger H. Idiopathic copper toxicosis. Am J Clin Nutr 1998; 67: 1082S-6S.

Mustafa MS, Shamina AH. Five successful deliveries following 9 consecutive spontaneous abortions in a patient with Wilson disease. Aust NZ J Obstet Gynaecol. 1998; 38: 312-14.

Baker A, Harvey L, Majask-Newman G, Fairweather-Tait S, Flynn A, Cashman K. Effect of dietary copper intakes on biochemical markers of bone metabolism in healthy adult males. Eur J Clin Nutr 1999; 53: 408-12.

Araya M, McGoldrick M., Klevay LM, Strain JJ, Robson P, Nielsen F et al. Determination of an acute no-observed- adverse-effect level (NOAEL) for copper in water. Regul Toxicol Pharmacol. 2001; 34: 137-45.

Araya M, Chen B, Klevay LM, Strain JJ, Johnson L, Robson P et al. Confirmation of an acute no-observed-adverse-effect level (NOAEL) and low-observed-adverse-effect level (LOAEL) forcopper in bottled drinking water in a multi-site international study. Regul Toxicol Pharmacol. 2003a;38:389- 99.

Araya M, Olivares M, Pizarro F, Gonzalez M, Speisky H, Uauy R. Gastrointestinal symptoms and blood indicators ofcopper load in apparently healthy adults undergoing controlled copper exposure. Am J Clin Nutr. 2003b ;77: 646- 50.

Janet Y, Uriu-Adams, Keen C L. Review. Copper, oxidative stress, and human health. Molecular Aspects of Medicine 2005;26(4-5): 268-98.https://doi.org/10.1016/j.mam. 2005.07.015

International Atomic Energy Agency (IAEA). Sampling, storage and sample preparation procedures for X ray fluorescence analysis of environmental materials.IAEA- TECDOC-950.1997.

Karatepe A, Soylak M, Elci L, Lett A, KarmausW, Brooks KR et al. Immune function biomarkers in children exposed to lead and organochlorine compounds: A cross-sectional study. Environ Health.2002; 4:1-10.

Jackson KM. Electro-thermal atomic absorption spectrometry and related techniques.Analytical Chemistry. 2000; 72 (12)

:159R-67R.

Levin AD, Pribytkov VA, Rukin EM, Seregina IF. Atomic- absorption spectrometry in the elemental analysis of biological materials, Measurement techniques. 2001; 44 (6) : 660-2.

Bader NR. Sample Preparation for Flame Atomic Absorption Spectroscopy: An Overview. Rasayan J Chem. 2011; 4(1): 49-55.

Barbosa Jr F, Santos JET, Gerlach RF, Parsons PJ. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect, 2005; 113(12): 1669-74.

Needham LL, Calafat AM, Barr DB. Needham Uses and issues of biomonitoring. Int J Hyg Environ Health, 2007; 210: 229-38.

Palmer CD, Lewis Jr ME, Geraghty CM, Barbosa Jr F, Parsons. Determination of lead, cadmium and mercury in blood for

Copper And Human Health- A Review

assessment of environmental exposure: A comparison between inductively coupled plasma - mass spectrometry and atomic absorption spectrometry. Spectrochim Acta Part B At Spectrosc. 2006; 61: 980-90.

Apostoli P. Elements in environmental and occupational medicine.J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 5;778(1-2):63-97. PMID:12376117.

Cypher GA. Copper and Human Health and Safety. International Copper Association Limited, 260 Madison Avenue, New York, NY 10016, USA.

Copper in Human Health. Technical Note TN 34, Copper Development Association, Orchard House, Mutton Lane, Potters Bar, Herts EN6 3AP, UK.

Brewer GJ. Iron and copper toxicity in diseases of aging , particularly atherosclerosis and Alzheimer's disease. Exp Biol Med. 2007; 232(2): 323-35.

Brewer GJ. Copper toxicity in the general population. Clin Neurophysiol. 2010; 121(4): 459-60.

Uauy R, Maass A, Araya M.Estimating risk from copper excess in human populations. The American Journal of Clinical Nutrition, 2008; 88(3): 867S 71S. doi.org/10.1093

/ajcn/88.3.867S

Downloads

Published

2018-06-04

How to Cite

Nasim Karim. (2018). Copper and Human Health- A Review. Journal of Bahria University Medical and Dental College, 8(2), 117–122. https://doi.org/10.51985/JBUMDC2018046

Issue

Section

Review Article